Oregon Health & Science University
Otolaryngology residency · Portland, OR · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Oregon Health & Science University's research in otolaryngology, which the program shares with other departments and affiliated hospitals.
About Oregon Health & Science Universityinstitution-wide otolaryngology research
Otolaryngology publications from Oregon Health & Science University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
13
works per year
24th of 56 otolaryngology residency programs
+12.5%
2-year growth
21st of 54 otolaryngology residency programs
31.4%
in top 10% of field (works before 2025)
10th of 39 otolaryngology residency programs
60.0%
cited above world average
10th of 39 otolaryngology residency programs
Works per year · * 2026 so far
Otorhinolaryngology · 64
Otolaryngology research topics at Oregon Health & Science University
Papers in the window; each links to the list on OpenAlex.
Most cited at Oregon Health & Science University since 2024
All otolaryngology papers there on OpenAlex
- Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO GuidelineF. Christopher Holsinger et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 68
- Clinical Practice Guideline: Adult Sinusitis UpdateSpencer C. Payne et al. · Otolaryngology · 2025 · PubMed · cited 48
- Health care disparities and chronic rhinosinusitis: Does neighborhood disadvantage impact outcomes in sinonasal disease?Amarbir S. Gill et al. · International Forum of Allergy & Rhinology · 2024 · PubMed · cited 12
- The Impact of Acute Peri-operative Particulate Matter Exposure on Endoscopic Sinus Surgery Outcomes: A Preliminary Multi-site InvestigationBenton Tullis et al. · American Journal of Rhinology and Allergy · 2024 · PubMed · cited 10
- RAC1-Amplified and RAC1-A159V Hotspot-Mutated Head and Neck Cancer Sensitive to the Rac Inhibitor EHop-016 In Vivo: A Proof-of-Concept StudyHelen Hoi Yin Chan et al. · Cancers · 2025 · PubMed · cited 9
- Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomyKeven Seung Yong Ji et al. · International Forum of Allergy & Rhinology · 2024 · PubMed · cited 7
- Reconstruction for Salvage Laryngectomy With Limited PharyngectomyMauricio Alejandro Moreno et al. · JAMA Otolaryngology–Head & Neck Surgery · 2024 · PubMed · cited 7
- Type 2 biomarkers in olfactory cleft mucus correlate with SNOT‐22 in chronic rhinosinusitis independent of nasal polyp statusNikita Chapurin et al. · International Forum of Allergy & Rhinology · 2024 · PubMed · cited 6
- Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative RiskR. Morse et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · PubMed · cited 6
- 868P Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)W. Douglas Wong et al. · Annals of Oncology · 2024 · cited 6